Organogenesis Company

Organogenesis Inc. is a regenerative medicine company.
Technology:
Cell therapy
Industry:
BioEngineering, Public
Headquarters:
Canton, Massachusetts, United States
Founded Date:
1985-01-01
Employees Number:
501-1000
Funding Status:
IPO
Investors Number:
3
Total Funding:
375000000
Estimated Revenue:
$100M to $500M
Last Funding Date:
2021-08-09
Last Funding Type:
Debt Financing
Register and Claim Ownership